| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.83B | 50.63B | 48.81B | 45.12B | 40.86B | 40.58B |
| Gross Profit | 23.20B | 22.48B | 20.92B | 18.16B | 17.38B | 17.31B |
| EBITDA | 6.00B | 5.65B | 5.40B | 4.22B | 3.88B | 4.09B |
| Net Income | 2.50B | 2.37B | 2.00B | 1.76B | 1.47B | 1.60B |
Balance Sheet | ||||||
| Total Assets | 65.69B | 68.63B | 64.73B | 63.91B | 60.69B | 58.57B |
| Cash, Cash Equivalents and Short-Term Investments | 17.61B | 19.16B | 16.43B | 16.94B | 17.91B | 16.84B |
| Total Debt | 4.13B | 3.50B | 3.02B | 3.84B | 2.91B | 2.18B |
| Total Liabilities | 15.00B | 16.04B | 15.49B | 15.14B | 13.75B | 12.20B |
| Stockholders Equity | 47.74B | 49.51B | 46.58B | 46.24B | 44.72B | 44.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.01B | 4.16B | -819.00M | 867.00M | 3.07B |
| Operating Cash Flow | 0.00 | 5.62B | 5.07B | 583.00M | 1.63B | 5.29B |
| Investing Cash Flow | 0.00 | -2.40B | -928.00M | -2.79B | -752.00M | -2.07B |
| Financing Cash Flow | 0.00 | -2.08B | -5.23B | -1.44B | -458.00M | -3.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥80.79B | 8.04 | ― | 0.82% | 7.10% | 36.47% | |
78 Outperform | ¥62.97B | 8.62 | ― | 3.69% | 4.46% | 127.52% | |
76 Outperform | ¥265.04B | 14.78 | ― | 2.42% | 9.55% | 9.52% | |
74 Outperform | ¥11.27B | 8.12 | ― | 3.98% | 4.35% | 7.25% | |
73 Outperform | ¥2.72T | 19.24 | 8.35% | 1.77% | 5.39% | 4.89% | |
73 Outperform | ¥153.72B | 14.99 | ― | 1.39% | 11.23% | 16.49% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |